Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction
Karin G. F. Gerritsen, Tri Q. Nguyen(Utrecht University), Jan Willem Leeuwis(University Medical Center Utrecht), Roel Goldschmeding(University Medical Center Utrecht), Stephan J. L. Bakker(University Medical Center Groningen), Jaap A. Joles(University Medical Center Utrecht), Maarten P. Koeners(University Medical Center Utrecht), Jan Aten(Amsterdam UMC Location University of Amsterdam), Lise Tarnow(Steno Diabetes Centers), Peter Rossing(Steno Diabetes Centers), Robbert J. Kok(Utrecht University), Willem van Oeveren(Dialyse Centrum Groningen), Jack F.M. Wetzels(Radboud University Nijmegen)
Cited by 24
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k